Book Cover
Home  |   Healthcare   |  Topical Skin Adhesive Market

Topical Skin Adhesive Market Size, Share, Growth, and Industry Analysis, By Type (2-Octyl Cyanoacrylate Adhesive, N-2-Butyl-Cyanoacrylate Adhesive, 2-Ethyl-Cyanoacrylate Adhesive, 2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate), By Application (Surgical Incisions, Trauma-Induced Lacerations, Burn and Skin Grafting, Others), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Topical Skin Adhesive Market Overview

The global Topical Skin Adhesive Market is projected to expand steadily from USD 328.92 Million in 2026 to USD 860.59 Million by 2035, representing a CAGR of 11.28% during 2026-2035.

The Topical Skin Adhesive Market is expanding as hospitals, ambulatory surgery centers, emergency departments, outpatient clinics, and physician practices increasingly adopt cyanoacrylate-based closure systems for fast, minimally invasive wound approximation. 2-Octyl Cyanoacrylate Adhesive accounts for an estimated 46% of product demand because it combines flexibility, strong wound-edge support, microbial barrier performance, and suitability for a broad range of surgical incisions. The market in 2026 is increasingly shaped by faster drying times, improved applicator control, mesh-assisted closure systems, antimicrobial barrier claims, and greater use of adhesives alongside deep dermal sutures. Manufacturers are also differentiating through sting-free formulations, precision tips, broad-coverage applicators, and products designed for large or high-tension incisions. These innovations are helping clinicians reduce closure time and improve cosmetic outcomes while supporting workflow efficiency in operating rooms and emergency care environments.

The United States remains one of the most important Topical Skin Adhesive Market environments because of its high surgical volumes, advanced hospital infrastructure, broad adoption of outpatient procedures, and established regulatory pathway for tissue adhesives. North America accounts for an estimated 39% of global demand, with the United States representing the majority through surgical incisions, trauma-induced lacerations, burn-related procedures, and other topical closure applications. Current products include octyl, butyl, and blended cyanoacrylate formulations, while mesh-assisted systems are expanding the addressable range toward longer or higher-tension wounds. Leading participants such as Ethicon (J&J), Advanced Medical Solutions, Medtronic, Chemence Medical, Medline, Adhezion Biomedical, Connexicon Medical, GluStitch, Meyer-Haake, and Aesculap (B. Braun) compete on adhesive chemistry, applicator ergonomics, drying speed, closure strength, and clinical usability.

Global Topical Skin Adhesive Market Size, 2035 (USD Million)

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Market Driver: Faster non-invasive wound closure is accelerating adoption, with approximately 68% of clinicians in high-volume surgical settings prioritizing adhesive systems that can reduce closure steps and improve operating-room workflow.
  • Major Market Restraint: Limited suitability for high-tension or poorly approximated wounds remains a key constraint, with approximately 24% of complex closure cases still requiring sutures, staples, or adjunct support.
  • Emerging Trends: Mesh-assisted adhesive systems are gaining momentum, with approximately 37% of advanced closure development programs focusing on larger incisions, higher tension, broader coverage, or improved reinforcement.
  • Regional Leadership: North America is expected to lead the Topical Skin Adhesive Market with approximately 39% share, supported by high surgical procedure volumes, strong outpatient adoption, and broad availability of advanced wound-closure products.
  • Competitive Landscape: Manufacturers are differentiating through applicator and formulation innovation, with approximately 32% of major development programs emphasizing faster polymerization, easier priming, broader coverage, or improved precision.
  • Market Segmentation: 2-Octyl Cyanoacrylate Adhesive is projected to lead product demand with approximately 46% share, while Surgical Incisions are expected to dominate applications at around 54% because of widespread operating-room use.
  • Recent Development: Regulatory expansion continued during 2026 as a leading supplier progressed topical adhesive approval in China, targeting commercial launch in the second half of the year.

Mesh-assisted and large-incision closure systems represent one of the strongest trends influencing the Topical Skin Adhesive Market in 2026. Approximately 37% of advanced closure development programs are now focused on extending adhesive use beyond simple low-tension incisions toward larger, longer, or more demanding wounds. New systems combine liquid cyanoacrylate with self-adhering mesh to maintain temporary edge alignment while the adhesive polymerizes, improving closure consistency and allowing topical adhesives to address a broader range of surgical procedures. Commercial products can maintain closure support for up to 14 days while providing fast dry times and microbial barrier performance. This development is particularly important in orthopedics, cardiovascular surgery, abdominal procedures, and other settings where clinicians want to reduce reliance on external staples while preserving secure approximation.

Applicator design and formulation engineering are also becoming major competitive differentiators. Approximately 43% of new topical skin adhesive products or updates emphasize easier priming, controlled flow, precision tips, rapid drying, or broader wound coverage. Current portfolios increasingly offer both octyl and butyl chemistries, as well as proprietary blends designed to balance flexibility, speed, viscosity, and strength. Some advanced applicators support wide and fine-line application from a single device, while others are optimized for emergency department use where rapid closure of trauma-induced lacerations is important. Manufacturers are also emphasizing water-resistant microbial barriers and reduced track marks compared with sutures or staples. The overall trend is toward simpler, faster, more predictable closure products that require less manipulation during application.

Topical Skin Adhesive Market Dynamics

Driver

"Faster minimally invasive wound closure is accelerating adhesive adoption."

The strongest driver of the Topical Skin Adhesive Market is increasing demand for wound-closure methods that reduce procedural steps while maintaining secure skin approximation. Approximately 68% of clinicians working in high-throughput surgical or emergency environments place strong value on closure systems that simplify application, reduce needle use, and shorten time at the skin layer. Topical adhesives can be applied without puncturing the skin and can eliminate the need for suture removal in suitable wounds. They also provide a protective polymer film over the incision and can support cosmetic outcomes without the visible track marks associated with external stitches or staples. These advantages are particularly relevant in minimally invasive surgery, ambulatory care, pediatric treatment, and emergency departments where speed and patient comfort are important.

Restraint

"Clinical limitations prevent adhesives from replacing all traditional closure methods."

The primary restraint affecting the Topical Skin Adhesive Market is that these products are not appropriate for every wound type. Approximately 24% of complex or high-tension closure cases still require sutures, staples, mesh reinforcement, or other adjunct methods because adhesive alone may not provide sufficient support. Topical skin adhesives are intended for easily approximated skin edges and are generally used in conjunction with, rather than instead of, deep dermal stitches when deeper tissue support is required. Irregular, contaminated, heavily bleeding, or highly mobile wounds can also be unsuitable. This limits the category’s ability to replace conventional closure techniques universally and requires clinicians to assess wound location, depth, contamination risk, and tension before choosing an adhesive.

Opportunity

"Advanced applicators and reinforced closure systems are expanding clinical use."

One of the strongest opportunities in the Topical Skin Adhesive Market comes from extending cyanoacrylate-based closure into broader surgical settings through improved formulations, applicators, and reinforcing materials. Approximately 37% of advanced product-development activity is focused on large-incision closure, reinforced systems, higher-tension applications, or more controlled delivery. Mesh-assisted products are particularly important because they allow adhesive technology to address wounds that may require more support than a simple liquid film can provide. This creates new opportunities in orthopedics, cardiovascular surgery, abdominal procedures, and other specialties where incision length and tension are greater. Manufacturers that combine strong wound approximation with rapid drying and easier handling are positioned to expand the practical range of adhesive closure beyond low-tension skin wounds.

Challenge

"Balancing fast curing with flexibility and control remains technically demanding."

A major challenge in the Topical Skin Adhesive Market is balancing rapid polymerization with adequate flexibility, viscosity, and application control. Approximately 29% of product-engineering effort is focused on optimizing cure speed without increasing brittleness or accidental flow. Faster-setting adhesives can improve clinical efficiency, but overly rapid curing can make repositioning difficult if wound edges are not perfectly aligned before application. More flexible chemistries, such as 2-Octyl Cyanoacrylate Adhesive, are often preferred for areas exposed to movement, while faster butyl-based products may suit other applications. Formulators must therefore carefully balance monomer composition, viscosity, polymer strength, and applicator design.

Topical Skin Adhesive Market Segmentation 

Global Topical Skin Adhesive Market Size, 2035

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

By Types

2-Octyl Cyanoacrylate Adhesive: 2-Octyl Cyanoacrylate Adhesive accounts for approximately 46% of the Topical Skin Adhesive Market and remains the leading product type because it provides a favorable balance of flexibility, wound strength, and skin compatibility. The longer alkyl chain produces a more flexible polymer film than shorter-chain cyanoacrylates, making it suitable for surgical incisions and body areas exposed to moderate movement. It is widely used across hospitals and outpatient settings where clinicians require secure closure and good cosmetic outcomes. The category also benefits from strong physician familiarity and broad use across many surgical specialties.

Approximately 62% of premium surgical adhesive use involves 2-Octyl Cyanoacrylate Adhesive or products in which octyl chemistry plays a central role. Manufacturers continue improving applicator ergonomics, coverage width, polymer consistency, and microbial barrier performance. The chemistry is particularly attractive for longer incisions when used with deep dermal sutures or reinforcing systems. Its leadership is expected to continue as hospitals increasingly prioritize flexible wound closure that can support recovery without external sutures or staples.

N-2-Butyl-Cyanoacrylate Adhesive: N-2-Butyl-Cyanoacrylate Adhesive represents approximately 24% of market demand and is valued for rapid polymerization, high bond strength, and efficient closure of smaller or lower-tension wounds. The material sets quickly after contact with moisture, making it useful in emergency departments and minor procedural environments where speed is important. It is also used in selected surgical incisions and trauma-induced lacerations where wound edges can be approximated easily.

Approximately 49% of N-2-Butyl-Cyanoacrylate Adhesive demand is associated with trauma care and minor surgical procedures. Its comparatively fast setting time can improve clinical throughput, although the resulting polymer is generally less flexible than octyl-based alternatives. Manufacturers are addressing this limitation through refined formulations, applicator controls, and blended chemistries. The segment is expected to remain significant because of its strong cost-performance balance and established use across diverse healthcare environments.

2-Ethyl-Cyanoacrylate Adhesive: 2-Ethyl-Cyanoacrylate Adhesive accounts for approximately 12% of the Topical Skin Adhesive Market and serves more specialized or cost-sensitive applications where rapid bonding and straightforward closure are required. The chemistry is known for fast polymerization and strong adhesion, but its lower flexibility compared with longer-chain cyanoacrylates limits use in some clinical settings. It is generally more suitable for short, low-tension wounds and selected applications where movement is minimal.

Approximately 38% of 2-Ethyl-Cyanoacrylate Adhesive usage is concentrated in smaller clinical procedures and specialized markets where lower cost is an important purchasing factor. Manufacturers continue working to improve purity, flow control, and tissue compatibility to increase clinical usability. While this segment is smaller than octyl- and butyl-based products, it remains relevant where hospitals and clinics require rapid closure at competitive cost and where wound characteristics are suitable for a more rigid adhesive film.

2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate: 2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate represents approximately 18% of market demand and combines the flexibility of octyl chemistry with the fast-setting characteristics of butyl-based adhesives. Blended formulations are designed to balance cure speed, mechanical strength, and flexibility, making them attractive for procedures where clinicians want both rapid application and improved wound adaptability.

Approximately 44% of blended adhesive development programs focus on optimizing polymerization time, viscosity, and elasticity for wider surgical use. These products can be especially useful where a single-component chemistry does not provide the preferred performance balance. As manufacturers continue refining blends and applicator systems, this segment is expected to gain share across hospitals seeking versatile products suitable for multiple wound types and clinical workflows.

By Applications

Surgical Incisions: Surgical Incisions account for approximately 54% of the Topical Skin Adhesive Market and represent the largest application segment because adhesives are increasingly used to close clean incisions after deep dermal layers have been secured. The technology is common in general surgery, orthopedics, cardiovascular procedures, gynecology, plastic surgery, and minimally invasive operations. Topical adhesives can reduce external suture requirements and create a protective barrier over the incision while improving cosmetic appearance.

Approximately 66% of adhesive-eligible surgical closures are performed in procedures where wound edges can be easily approximated and deep tension is managed beneath the skin. Growth is supported by rising outpatient surgery volumes, shorter hospital stays, and demand for efficient closure methods. Mesh-assisted systems are broadening the range of incision lengths and tension levels that can be managed with topical adhesives, strengthening this application’s leadership.

Trauma-Induced Lacerations: Trauma-Induced Lacerations represent approximately 23% of market demand and include cuts, minor accidental wounds, and emergency injuries treated in hospitals, urgent-care centers, and physician offices. Topical adhesives are particularly useful for clean, low-tension lacerations because they can provide rapid closure without local needle-based suturing in selected cases. This can improve patient comfort and shorten treatment time.

Approximately 57% of suitable pediatric laceration cases are candidates for adhesive closure when wound depth, contamination, and tension conditions are appropriate. The absence of needle placement can reduce anxiety in children and adults who are uncomfortable with suturing. Emergency departments also benefit from faster turnover and reduced need for suture-removal follow-up. The segment continues to grow as clinicians gain experience with different applicators and wound types.

Burn and Skin Grafting: Burn and Skin Grafting accounts for approximately 11% of the Topical Skin Adhesive Market and includes selected donor-site closure, graft fixation, and wound-management applications. Adhesives can assist in stabilizing skin edges or graft materials when used appropriately alongside other wound-care techniques. Their potential to reduce mechanical fixation makes them attractive in procedures where minimizing additional tissue trauma is important.

Approximately 34% of advanced burn and grafting protocols evaluate adhesive-based closure or fixation as an adjunct to sutures, staples, dressings, or other wound-management methods. Adoption remains more specialized because burn wounds vary significantly in depth, contamination, and tissue quality. However, improved formulations and precision applicators are creating new opportunities for controlled use in reconstructive and graft-related procedures.

Others: Others represent approximately 12% of market demand and include dermatologic procedures, minor office-based surgery, selected cosmetic interventions, catheter-site closure, and other specialized skin-closure applications. These procedures often involve small incisions where rapid closure and cosmetic appearance are important. Adhesive-based approaches can be especially useful when clinicians want to avoid suture removal or minimize procedure time.

Approximately 41% of demand within Others comes from dermatology and cosmetic-procedure settings where visible scarring and patient convenience strongly influence closure choice. Providers increasingly value products with precise applicators and flexible polymer films that can be used on small facial or body incisions. Growth in outpatient procedural medicine is expected to support steady expansion of this segment over the forecast period.

Topical Skin Adhesive Market Regional Outlook

Global Topical Skin Adhesive Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

North America

North America accounts for approximately 39% of the Topical Skin Adhesive Market, supported by high surgical volumes, advanced hospital infrastructure, broad adoption of minimally invasive procedures, and strong utilization of cyanoacrylate-based wound closure. The United States contributes the majority of regional demand as hospitals and ambulatory centers increasingly use topical adhesives for Surgical Incisions and Trauma-Induced Lacerations. Clinical preference is being strengthened by faster application, reduced need for suture removal, and improved cosmetic outcomes in suitable wounds. 2-Octyl Cyanoacrylate Adhesive remains the dominant formulation across higher-value surgical applications, while butyl-based products continue to serve emergency and minor-procedure settings.

Approximately 64% of large hospitals and ambulatory surgery centers in the region use topical skin adhesives within at least one standardized closure pathway. Companies including Ethicon (J&J), Medtronic, Medline, Chemence Medical, Adhezion Biomedical, and Advanced Medical Solutions compete through applicator design, adhesive chemistry, drying time, and reinforcement systems. Outpatient procedures are particularly important to regional growth because products that reduce dressing complexity and follow-up requirements fit well within same-day surgery models. Continued product approvals and expanded clinical indications are expected to support steady adoption through the forecast period.

Europe

Europe represents approximately 27% of the Topical Skin Adhesive Market, supported by mature healthcare systems, high surgical standards, strong medical-device regulation, and growing adoption of minimally invasive closure technologies. Germany, the United Kingdom, France, Italy, Spain, and Nordic markets are important contributors. Surgical Incisions account for most demand, while Trauma-Induced Lacerations and selected Burn and Skin Grafting procedures provide additional opportunities. Hospitals increasingly evaluate adhesives based on application speed, flexibility, microbial barrier performance, and cost relative to conventional external sutures or staples.

Approximately 49% of major European surgical centers have expanded use of adhesive-based wound closure during selected procedures where skin tension is moderate and deep layers are secured separately. Aesculap (B. Braun), Advanced Medical Solutions, Connexicon Medical, and other listed companies benefit from regional demand for high-quality closure products and clinician training support. European healthcare systems also emphasize standardization and cost efficiency, encouraging suppliers to demonstrate reduced procedural steps and favorable patient outcomes. Adoption is expected to increase gradually as mesh-assisted systems broaden the range of suitable incisions.

Asia-Pacific

Asia-Pacific accounts for approximately 24% of the Topical Skin Adhesive Market and is expanding quickly as surgical capacity, private healthcare investment, outpatient treatment, and medical-device access increase across China, Japan, South Korea, India, Australia, and Southeast Asia. Demand is being supported by growing use of minimally invasive procedures and rising preference for faster wound closure technologies. Surgical Incisions remain the primary application, while emergency departments and ambulatory centers increasingly use adhesives for selected lacerations.

Approximately 52% of incremental market demand in Asia-Pacific is associated with China, Japan, India, and South Korea, where healthcare infrastructure continues to modernize. Manufacturers are increasingly pursuing local regulatory approvals, distributor partnerships, and clinician education programs to accelerate adoption. Lower-cost butyl and ethyl formulations remain relevant in price-sensitive settings, while premium octyl and blended products gain share in larger hospitals and private healthcare systems. Asia-Pacific is expected to remain one of the fastest-growing regional markets as procedure volumes and healthcare access continue rising.

Middle East and Africa

Middle East and Africa represents approximately 6% of the Topical Skin Adhesive Market, with demand concentrated in Gulf countries, South Africa, and major urban healthcare centers. Hospitals are gradually increasing adoption of advanced closure technologies as surgical services modernize and private healthcare expands. Topical adhesives are particularly attractive in outpatient procedures where rapid closure and reduced follow-up requirements can improve operational efficiency. Surgical Incisions remain the leading application, while Trauma-Induced Lacerations provide additional demand in emergency departments.

Approximately 31% of premium private hospitals in leading Gulf markets use topical skin adhesives in selected surgical specialties. Adoption across Africa remains more uneven because product availability, reimbursement, and clinician familiarity vary by country. However, medical-device distributors are expanding access to standardized cyanoacrylate systems in larger cities. Long-term growth will depend on healthcare investment, surgeon education, and availability of products with reliable storage, clear instructions, and competitive pricing.

Rest of the World

Rest of the World accounts for approximately 4% of the Topical Skin Adhesive Market, with Latin America representing the largest portion. Brazil, Mexico, Argentina, Chile, and other markets are gradually increasing use of adhesive closure in private hospitals, emergency departments, and outpatient facilities. Adoption is strongest where clinicians seek faster closure for low-tension wounds and where reducing return visits for suture removal is beneficial.

Approximately 28% of large private surgical facilities in selected Latin American markets use topical adhesives across at least one standardized procedure type. Demand is influenced by product price, import regulations, clinician preference, and distribution coverage. Lower-cost formulations remain important, although premium 2-Octyl Cyanoacrylate Adhesive is gaining traction in higher-value procedures where flexibility and cosmetic outcome are prioritized. Regional growth is expected to remain steady as healthcare access and ambulatory surgery expand.

List of Top Topical Skin Adhesive Market Companies

  • Ethicon (J&J)
  • Aesculap (B. Braun)
  • Advanced Medical Solutions
  • Medtronic
  • Chemence Medical
  • Medline
  • Adhezion Biomedical
  • Connexicon Medical
  • GluStitch
  • Meyer-Haake

Top 2 Companies with Highest Market Share

  • Ethicon (J&J): Holds an estimated 22% share among the listed companies, supported by strong global hospital penetration, broad 2-Octyl Cyanoacrylate Adhesive adoption, mesh-assisted closure systems, and extensive clinician familiarity.
  • Advanced Medical Solutions: Accounts for an estimated 14% share among the listed companies, supported by broad surgical adhesive expertise, expanding international distribution, advanced applicator technologies, and a growing portfolio of cyanoacrylate-based wound closure products.

Investment Analysis and Opportunities

Investment in the Topical Skin Adhesive Market is increasingly directed toward reinforced closure systems, next-generation applicators, faster polymerization, and expansion into outpatient surgical settings. Approximately 41% of major investment activity is focused on products that can broaden adhesive use beyond simple low-tension wounds. Mesh-assisted systems are particularly attractive because they can improve closure strength while maintaining a needle-free skin-surface approach. Companies are also investing in regulatory approvals, clinical evidence, manufacturing automation, and sterile packaging to support geographic expansion.

Asia-Pacific and emerging healthcare markets provide significant growth opportunities, with approximately 45% of future incremental demand expected from regions where surgical volumes and ambulatory care are rising rapidly. Suppliers that can provide room-temperature storage, intuitive applicators, competitive pricing, and strong clinician education are likely to benefit. Additional opportunities exist in pediatric care, dermatology, cosmetic procedures, and emergency medicine. Strategic investment in local distribution and regulatory pathways can accelerate adoption where conventional sutures remain dominant but healthcare systems are seeking faster and more patient-friendly closure methods.

New Product Development

New product development is increasingly focused on improving closure strength without sacrificing flexibility or application speed. Approximately 38% of new product programs are centered on reinforced adhesive systems, blended cyanoacrylate chemistries, or applicators that improve control across longer incisions. Manufacturers are also developing products that spread more evenly and polymerize predictably under varying clinical conditions. These advances are particularly relevant to surgical specialties where longer wounds and greater movement can challenge simple adhesive films.

Applicator innovation remains another major development area, with approximately 43% of new designs emphasizing precision tips, broader coverage, easier priming, or controlled-flow functionality. Suppliers are working to reduce accidental dripping, premature curing, and waste while giving clinicians more consistent application. New formulations also target improved flexibility, reduced brittleness, and faster drying. The combination of chemistry and applicator design is expected to determine competitive differentiation as hospitals increasingly compare products on total workflow performance rather than adhesive chemistry alone.

Five Recent Developments

  • January 2026 – Reinforced Closure Systems Expand: Manufacturers increased development of mesh-assisted and stronger adhesive platforms, with approximately 34% of new closure programs focused on supporting longer incisions and higher-tension applications.
  • March 2026 – Fast-Dry Formulations Gain Wider Adoption: Hospitals and ambulatory centers increased use of rapid-polymerizing cyanoacrylate systems, with approximately 31% of product updates emphasizing shorter drying time and improved procedural efficiency.
  • April 2026 – Precision Applicator Designs Improve: Medical-device developers expanded controlled-flow applicators, with approximately 29% of new product enhancements targeting easier priming, reduced dripping, and more accurate adhesive placement.
  • June 2026 – Outpatient Procedure Adoption Accelerates: Topical skin adhesive use increased in same-day surgery settings, with approximately 36% of targeted adoption programs focused on reducing closure time, follow-up requirements, and external suture use.
  • July 2026 – Asia Regulatory Expansion Strengthens: Leading suppliers advanced approvals and commercial preparation across major Asian healthcare markets, with approximately 27% of geographic expansion initiatives centered on China and other high-growth surgical environments.

Report Coverage

The Topical Skin Adhesive Market report covers 2-Octyl Cyanoacrylate Adhesive, N-2-Butyl-Cyanoacrylate Adhesive, 2-Ethyl-Cyanoacrylate Adhesive, and 2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate across Surgical Incisions, Trauma-Induced Lacerations, Burn and Skin Grafting, and Others applications. 2-Octyl Cyanoacrylate Adhesive accounts for approximately 46% of product demand because of its flexibility, closure strength, microbial barrier performance, and broad suitability across hospital and outpatient procedures. The report evaluates adhesive chemistry, polymerization speed, applicator design, reinforced closure systems, clinical workflow, wound tension, microbial protection, outpatient surgery, trauma care, burn treatment, and cosmetic outcomes. Surgical Incisions remain the largest supplied application because hospitals increasingly use topical adhesives as an alternative or adjunct to sutures and staples where wound characteristics are appropriate.

The regional analysis covers North America, Europe, Asia-Pacific, Middle East and Africa, and Rest of the World, with North America accounting for approximately 39% of overall market demand. Competitive coverage includes Ethicon (J&J), Aesculap (B. Braun), Advanced Medical Solutions, Medtronic, Chemence Medical, Medline, Adhezion Biomedical, Connexicon Medical, GluStitch, and Meyer-Haake. The report also evaluates investment opportunities associated with mesh-assisted closure, advanced applicators, blended cyanoacrylate formulations, outpatient adoption, geographic regulatory expansion, and clinician training. Particular attention is given to how manufacturers are balancing cure speed, flexibility, strength, ease of application, and broader procedural suitability as topical skin adhesives become more integrated into modern wound-closure pathways.

Topical Skin Adhesive Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 328.92 Million in 2026

Market Size Value By

USD 860.59 Million by 2035

Growth Rate

CAGR of 11.28% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • 2-Octyl Cyanoacrylate Adhesive
  • N-2-Butyl-Cyanoacrylate Adhesive
  • 2-Ethyl-Cyanoacrylate Adhesive
  • 2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate

By Application :

  • Surgical Incisions
  • Trauma-Induced Lacerations
  • Burn and Skin Grafting
  • Others

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Topical Skin Adhesive Market is expected to reach USD 860.59 Million by 2035.

The Topical Skin Adhesive Market is expected to exhibit a CAGR of 11.28% by 2035.

Ethicon (J&J), Aesculap (B. Braun), Advanced Medical Solutions, Medtronic, Chemence Medical, Medline, Adhezion Biomedical, Connexicon Medical, GluStitch, Meyer-Haake

In 2026, the Topical Skin Adhesive Market value will reach at USD 328.92 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified